Suppr超能文献

鱼油与华法林的相互作用。

Fish oil interaction with warfarin.

作者信息

Buckley Mitchell S, Goff Angela D, Knapp Walter E

机构信息

Shawnee Mission Medical Center, Shawnee Mission, KS of Arizona, Tucson, AZ 85724, USA.

出版信息

Ann Pharmacother. 2004 Jan;38(1):50-2. doi: 10.1345/aph.1D007.

Abstract

OBJECTIVE

To report a case of elevated international normalized ratio (INR) in a patient taking fish oil and warfarin.

CASE SUMMARY

A 67-year-old white woman had been taking warfarin for 1(1/2) years due to recurrent transient ischemic attacks. Her medical history included hypothyroidism, hyperlipidemia, osteopenia, hypertension, and coronary artery disease. She also experienced an inferior myocardial infarction in 1995 requiring angioplasty, surgical repair of her femoral artery in 1995, and hernia repair in 1996. This patient has her INR checked in the anticoagulation clinic and is followed monthly by the clinical pharmacist. Prior to the interaction, her INR was therapeutic for 5 months while she was taking warfarin 1.5 mg/d. The patient admitted to doubling her fish oil dose from 1000 to 2000 mg/d. Without dietary, lifestyle, or medication changes, the INR increased from 2.8 to 4.3 within 1 month. The INR decreased to 1.6 one week after subsequent fish oil reduction, necessitating a return to the original warfarin dosing regimen.

DISCUSSION

Fish oil supplementation could have provided additional anticoagulation with warfarin therapy. Fish oil, an omega-3 polyunsaturated fatty acid, consists of eicosapentaenoic acid and docosahexaenoic acid. This fatty acid may affect platelet aggregation and/or vitamin K-dependent coagulation factors. Omega-3 fatty acids may lower thromboxane A(2) supplies within the platelet as well as decrease factor VII levels. Although controversial, this case report illustrates that fish oil can provide additive anticoagulant effects when given with warfarin.

CONCLUSIONS

This case reveals a significant rise in INR after the dose of concomitant fish oil was doubled. Patients undergoing anticoagulation therapy with warfarin should be educated about and monitored for possible drug-herb interactions. Pharmacists can play a crucial role in identifying possible drug interactions by asking patients taking warfarin about herbal and other alternative medicine product use.

摘要

目的

报告一例服用鱼油和华法林的患者国际标准化比值(INR)升高的病例。

病例摘要

一名67岁白人女性因复发性短暂性脑缺血发作服用华法林1年半。她的病史包括甲状腺功能减退、高脂血症、骨质减少、高血压和冠状动脉疾病。她还在1995年发生过下壁心肌梗死,需要进行血管成形术;1995年接受了股动脉手术修复;1996年进行了疝气修补术。该患者在抗凝门诊检查INR,临床药师每月对其进行随访。在相互作用之前,她服用1.5毫克/天的华法林时,INR在5个月内处于治疗水平。患者承认将鱼油剂量从1000毫克/天加倍至2000毫克/天。在饮食、生活方式或药物未改变的情况下,INR在1个月内从2.8升至4.3。在随后减少鱼油剂量一周后,INR降至1.6,因此需要恢复至原来的华法林给药方案。

讨论

补充鱼油可能对华法林治疗起到额外的抗凝作用。鱼油是一种ω-3多不饱和脂肪酸,由二十碳五烯酸和二十二碳六烯酸组成。这种脂肪酸可能会影响血小板聚集和/或维生素K依赖的凝血因子。ω-3脂肪酸可能会降低血小板内血栓素A2的供应,同时降低因子VII水平。尽管存在争议,但本病例报告表明,鱼油与华法林合用时可产生相加的抗凝作用。

结论

本病例显示,伴随服用的鱼油剂量加倍后,INR显著升高。接受华法林抗凝治疗的患者应接受有关可能的药物-草药相互作用的教育并接受监测。药剂师通过询问服用华法林的患者有关草药和其他替代药品的使用情况,在识别可能的药物相互作用方面可发挥关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验